Join
Live feed
·
INSIDERFilingvia Quantisnow
Impact BioMedical Inc. logo

Chief Executive Officer Heuszel Frank D bought $2,739 worth of shares (1,050 units at $2.61), increasing direct ownership by 1% to 96,344 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBO (Impact BioMedical Inc.) and more on Quantisnow.